HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $20
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen maintains a 'Buy' rating on AngioDynamics (NASDAQ:ANGO) and raises the price target from $19 to $20.
October 05, 2023 | 11:12 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The 'Buy' rating maintained by HC Wainwright & Co. and the raised price target could potentially boost investor confidence in AngioDynamics.
Analyst ratings and price targets can significantly influence investor sentiment. The maintained 'Buy' rating and increased price target from HC Wainwright & Co. suggest a positive outlook for AngioDynamics, which could lead to increased investor interest and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100